• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD¿ CD2 PE-CY7 CE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD¿ CD2 PE-CY7 CE Back to Search Results
Catalog Number 335821
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/14/2022
Event Type  malfunction  
Event Description
It was reported that upon receipt of bd¿ cd2 pe-cy7 ce that incorrect label information was identified.The following information was provided by the initial reporter: "clone name suddenly changed on the vial, but also differs from ifu.Customer is very surprised in the past the #335821 was the clone s5.2 now it suddenly changed to the l303.1, how can this be? the ifu still states the s5.2 clone, but the product label doesn't! so old 335821 is lot number 1067111 is clone s5.2, latest 335821 is lot number 1350866 and has the changed clone l303.1.This is very strange! see extra photo's with the details! we have recently ordered the cd2 pe-cy7, previously it was always clone s5.2 article no 335821 (this is also still on the jar we are using now).Now we have received: cd2 pe-cy7 clone l303.1 but the package insert is from clone s5.2.The article number on this jar with the other clone is also 335821, the same as the package leaflet of s5.2.".
 
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
The following fields have been updated with additional information: d9: device available for eval? yes.H2: device return to manuf.?: no.H2: device eval by manufacturer?: yes.Scope of issue: the scope of issue is limited to cd2 (l303.1) pe-cy¿7 in m/n 335821 lot no.1350866.Problem statement: customer reported clone name suddenly changed on the vial, but also differs from ifu for cd2 (l303.1) pe-cy¿7 in m/n 335821 lot no.1350866.Manufacturing defect trend: there are no qns related to the reported issue.Date range from 14apr2021 to date 14apr2022 (rolling 12 months).Complaint trend: there are 2 related complaints.Date ranges from date 14apr2021 to date 14apr2022 (rolling 12 months).Batch history record (bhr) review: batch record 335821-1350866 was reviewed.Batch history record was reviewed.During the manufacturing of m/n 335821 lot no.1350866, the bom called for vial label 23-7300-03 which contains the correct clone l303.1.The bom also called for product insert assembly 23-6188-03.This product insert assembly contains the down revision product insert that contains the clone s5.2 which is the incorrect clone for 335821.Thus, the complaint is confirmed.Retain sample evaluation / testing: retain testing not required since this is not a reagent performance issue.Returned sample evaluation: return sample was not requested since this is not a reagent performance issue.Investigation result / analysis: customer reported clone name suddenly changed on the vial, but also differs from ifu for cd2 (l303.1) pe-cy¿7 in m/n 335821 lot no.1350866.Based on the batch history review, product defect was found.Complaint was confirmed.Risk analysis: risk analysis: risk management for material 335821 (100310ra, revision 02) was reviewed.Hazard(s) identified? yes; no.Hazard: information hazard.Cause: inadequate instructions provided by bd.Harmful effects: unable to perform testing.Delay in diagnosis.Severity: 3.Probability: 1.Implementation verification: technical datasheet.Effectiveness verification: verified by label approval process.Risk index: 3.Mitigation(s) sufficient: yes; no.Root cause analysis: root cause is bom is not updated with the current product insert.Conclusion: based on the investigation result, complaint was confirmed.
 
Event Description
It was reported that upon receipt of bd¿ cd2 pe-cy7 ce that incorrect label information was identified.The following information was provided by the initial reporter: "clone name suddenly changed on the vial, but also differs from ifu customer is very surprised in the past the #335821 was the clone s5.2 now it suddenly changed to the l303.1, how can this be? the ifu still states the s5.2 clone, but the product label doesn't! so old 335821 is lotnumber 1067111 is clone s5.2, latest 335821 is lotnumber 1350866 and has the changed clone l303.1.This is very strange! see extra photo's with the details! we have recently ordered the cd2 pe-cy7, previously it was always clone s5.2 article no 335821 (this is also still on the jar we are using now) now we have received: cd2 pe-cy7 clone l303.1 but the package insert is from clone s5.2 the article number on this jar with the other clone is also 335821, the same as the package leaflet of s5.2.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD¿ CD2 PE-CY7 CE
Type of Device
NA
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer (Section G)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14739508
MDR Text Key302182527
Report Number2647876-2022-00161
Device Sequence Number1
Product Code MVU
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/31/2022
Device Catalogue Number335821
Device Lot Number1350866
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/09/2022
Initial Date FDA Received06/17/2022
Supplement Dates Manufacturer Received07/27/2022
Supplement Dates FDA Received08/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/16/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-